SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 225.97 |
Enterprise Value ($M) | 182.33 |
Book Value ($M) | 70.14 |
Book Value / Share | 1.28 |
Price / Book | 3.22 |
NCAV ($M) | 67.53 |
NCAV / Share | 1.23 |
Price / NCAV | 3.35 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.65 |
Return on Assets (ROA) | -0.75 |
Return on Equity (ROE) | -0.84 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.78 |
Current Ratio | 6.97 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 79.45 |
Assets | 82.06 |
Liabilities | 11.92 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -48.96 |
Net Income | -46.34 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -38.41 |
Cash from Investing | -17.06 |
Cash from Financing | 55.92 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Nomura Holdings Inc | 5.40 | -0.20 | |
13G | Vanguard Group Inc | 5.15 | ||
13G | BlackRock Inc. | 6.40 | 449.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
106,527 | 331,516 | 32.13 | |
96,996 | 455,547 | 21.29 | |
59,503 | 489,686 | 12.15 | |
86,268 | 381,421 | 22.62 | |
(click for more detail) |
Similar Companies | |
---|---|
CHRS – Coherus BioSciences, Inc. | CLSD – Clearside Biomedical, Inc. |
CMRX – Chimerix, Inc. | CRON – Cronos Group Inc. |
CRSP – CRISPR Therapeutics AG |